NAZARETH HOSPITAL
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- -
- Employees
- -
- Market Cap
- -
Clinical Trials
11
Active:0
Completed:3
Trial Phases
2 Phases
Phase 4:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (75.0%)Phase 4
1 (25.0%)Metoclopramide in Upper Gastrointestinal Bleed
Phase 4
Recruiting
- Conditions
- Bleeds GastricHemorrhage GastricBleed UlcerUpper GI BleedingHemorrhage; Ulcer
- Interventions
- Drug: Saline
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Mercy Health System
- Target Recruit Count
- 60
- Registration Number
- NCT05746377
- Locations
- 🇺🇸
Javon Bea Hospital-Riverside - MercyHealth, Rockford, Illinois, United States
The Effects of Probiotic Supplementation on Extremely Low Birthweight Infants
Not Applicable
Terminated
- Conditions
- Feeding Tolerance
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Mercy Health System
- Target Recruit Count
- 133
- Registration Number
- NCT01788761
- Locations
- 🇺🇸
Rockford Memorial Hospital, Rockford, Illinois, United States
Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
Not Applicable
- Conditions
- ObesityMorbid ObesityVenous ThromboembolismAtrial FibrillationAnginaChest Pain
- First Posted Date
- 2011-06-01
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Nazareth Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01363193
- Locations
- 🇺🇸
Nazareth Hospital - Mercy Health System, Philadelphia, Pennsylvania, United States
News
No news found